Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Loss of Lepr in Fibroblasts Drives Tumor Development by Promoting Macrophage Infiltration.

Created on 01 Nov 2026

Authors

Manyu Song, Wuqi Yang, Bangran Qi, Liyuan Hou, Xu Yang, Jiuzhi Xu, Shengyuan Tian, Shuiling Jin, Lu Yu, Zhengquan Yu, Min Deng, Jiaqiang Huang, Suoqin Jin, Cong Lv

Published in

Advanced science (Weinheim, Baden-Wurttemberg, Germany). Oct 31, 2026. Epub Oct 31, 2026.

Abstract

Cancer-associated fibroblasts (CAFs) are critical regulators of colorectal cancer (CRC) progression, yet the mechanisms governing their functional plasticity and state transitions remain incompletely understood. Here, we uncover a tumor-driven fibroblast state transition in CRC characterized by loss of leptin receptor (Lepr) expression and acquisition of pro-inflammatory features. We show that cooperative TNFα and TGFβ signaling drives this reprogramming, accompanied by repression of the Tcf21-Lepr regulatory axis. Fibroblasts undergoing this transition acquire the capacity to promote macrophage recruitment and accelerate tumor development. Loss of Lepr or Tcf21 in fibroblasts upregulates Csf3, which contributes to the enhanced macrophage-recruiting capacity of the reprogrammed fibroblasts. Consistently, blockade of TNFα and TGFβ signaling disrupts fibroblast reprogramming and attenuates macrophage infiltration. Together, our findings uncover how inflammatory signaling reshapes stromal cell states to promote macrophage accumulation, ultimately fostering a pro-tumorigenic niche that accelerates CRC progression.

PMID:
42966878
Bibliographic data and abstract were imported from PubMed on 01 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement